$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Rubitidine can be used to treat adult patients with metastatic small cell lung cancer (SCLC)_Cornhule
2025-10-19 11:44:20
Check Details
Rubitidine can significantly improve the survival of patients with small cell lung cancer
2025-10-19 11:44:20
Check Details
Where is the new small cell lung cancer drug rupitidine available? How much does it cost?
2025-10-19 11:44:20
Check Details
Rubitidine has significant effect in the treatment of metastatic small cell lung cancer
2025-10-19 11:44:20
Check Details
New treatment option for small cell lung cancer: rupitidine
2025-10-19 11:44:20
Check Details
The emergence of rubitidine gives patients with small cell lung cancer new hope
2025-10-19 11:44:20
Check Details
Contraindications and precautions for patients with lung cancer taking rupitidine
2025-10-19 11:44:20
Check Details
Small cell lung cancer welcomes new treatment drug: rupitidine
2025-10-19 11:44:20
Check Details
Can trametinib combined with dabrafenib be used to treat mutant advanced NSCLC?
2025-10-19 11:44:20
Check Details
Where can I buy Apellis? What's the price?
2025-10-19 11:44:20
Check Details
The overall response rate of ceritinib (Zanda) in the treatment of lung cancer can reach 72.5%_ Kanghule
2025-10-19 11:44:20
Check Details
Is ceritinib (Zanda) a new option after crizotinib resistance
2025-10-19 11:44:20
Check Details
1
2
...
3881
3882
3883
3884
3885
3886
3887
...
4156
4157
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
2
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
3
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
4
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
5
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
6
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
7
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
8
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
9
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
10
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
11
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
12
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer